{"nctId":"NCT01318135","briefTitle":"Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan","startDateStruct":{"date":"2009-01"},"conditions":["Type 2 Diabetes Mellitus"],"count":576,"armGroups":[{"label":"Alogliptin 12.5 mg QD and Glimepiride 1- 6 mg QD or BID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Alogliptin and glimepiride"]},{"label":"Alogliptin 25 mg QD and Glimepiride 1 - 6 mg QD or BID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Alogliptin and glimepiride"]},{"label":"Alogliptin 12.5 mg QD and Metformin 500 mg BID or 750 mg TID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Alogliptin and metformin"]},{"label":"Alogliptin 25 mg QD and Metformin 500 mg BID or 750 mg TID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Alogliptin and metformin"]}],"interventions":[{"name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"name":"Alogliptin and glimepiride","otherNames":["SYR-322","Amaryl"]},{"name":"Alogliptin and metformin","otherNames":["SYR-322","Glycoran"]},{"name":"Alogliptin and metformin","otherNames":["SYR-322","Glycoran"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nCommon criteria that applied to participants completing both the core phase 2/3 sulfonylurea add-on study and those completing the core phase 2/3 metformin add-on study:\n\n1. Had completed the core phase 2/3 sulfonylurea add-on study or the core phase 2/3 metformin add-on study.\n2. Was capable of understanding and complying with protocol requirements.\n3. Signed a written informed consent form prior to the initiation of any study procedure.\n\nExclusion Criteria:\n\nCommon criteria that applied to participants completing both the core phase 2/3 sulfonylurea add-on study and those completing the core phase 2/3 metformin add-on study:\n\n1. With clinical manifestation of hepatic impairment (eg, an aspartate aminotransferase or alanine aminotransferase value of 2.5 times or more of the upper reference limit at Week 8 of the core phase 2/3 sulfonylurea add-on study or the core phase 2/3 metformin add-on study).\n2. With clinical manifestation of renal impairment (eg, a creatinine value of 1.5 times or more of the upper reference limit at Week 8 of the core phase 2/3 sulfonylurea add-on study or the core phase 2/3 metformin add-on study).\n3. With serious cardiac disease, cerebrovascular disorder, or serious pancreatic or hematological disease (eg, a subject who requires hospital admission).\n\nCriteria that applied only to participants completing the core phase 2/3 metformin add-on study:\n\n1\\. With history or symptoms of lactic acidosis.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"64 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events.","description":"Treatment-emergent adverse events (TEAE) are defined as any unfavorable and unintended sign, symptom or disease temporally associated with the use of a medicinal product reported from first dose of study drug through 30 days after receiving the last dose of study drug. A TEAE may also be a pretreatment adverse event or a concurrent medical condition diagnosed prior to the date of first dose of study drug that increases in severity after the start of dosing.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116","spread":null},{"groupId":"OG001","value":"134","spread":null},{"groupId":"OG002","value":"108","spread":null},{"groupId":"OG003","value":"113","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 8).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 8 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.53","spread":"0.506"},{"groupId":"OG001","value":"-0.65","spread":"0.515"},{"groupId":"OG002","value":"-0.53","spread":"0.486"},{"groupId":"OG003","value":"-0.59","spread":"0.394"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 12).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 12 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.63","spread":"0.626"},{"groupId":"OG001","value":"-0.72","spread":"0.589"},{"groupId":"OG002","value":"-0.61","spread":"0.576"},{"groupId":"OG003","value":"-0.71","spread":"0.489"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 16).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 16 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.685"},{"groupId":"OG001","value":"-0.76","spread":"0.660"},{"groupId":"OG002","value":"-0.69","spread":"0.614"},{"groupId":"OG003","value":"-0.78","spread":"0.495"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 20).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 20 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.63","spread":"0.754"},{"groupId":"OG001","value":"-0.70","spread":"0.689"},{"groupId":"OG002","value":"-0.67","spread":"0.648"},{"groupId":"OG003","value":"-0.78","spread":"0.553"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 24).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 24 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.823"},{"groupId":"OG001","value":"-0.70","spread":"0.740"},{"groupId":"OG002","value":"-0.68","spread":"0.668"},{"groupId":"OG003","value":"-0.78","spread":"0.623"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 28).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 28 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.62","spread":"0.841"},{"groupId":"OG001","value":"-0.76","spread":"0.721"},{"groupId":"OG002","value":"-0.70","spread":"0.659"},{"groupId":"OG003","value":"-0.84","spread":"0.596"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 32).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 32 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.63","spread":"0.868"},{"groupId":"OG001","value":"-0.77","spread":"0.736"},{"groupId":"OG002","value":"-0.67","spread":"0.644"},{"groupId":"OG003","value":"-0.81","spread":"0.634"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 36).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 36 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.64","spread":"0.881"},{"groupId":"OG001","value":"-0.77","spread":"0.745"},{"groupId":"OG002","value":"-0.67","spread":"0.659"},{"groupId":"OG003","value":"-0.79","spread":"0.653"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 40).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 40 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.799"},{"groupId":"OG001","value":"-0.74","spread":"0.779"},{"groupId":"OG002","value":"-0.63","spread":"0.676"},{"groupId":"OG003","value":"-0.74","spread":"0.698"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 44).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 44 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.48","spread":"0.726"},{"groupId":"OG001","value":"-0.71","spread":"0.666"},{"groupId":"OG002","value":"-0.47","spread":"0.787"},{"groupId":"OG003","value":"-0.70","spread":"0.688"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 48).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 48 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.40","spread":"0.706"},{"groupId":"OG001","value":"-0.61","spread":"0.660"},{"groupId":"OG002","value":"-0.36","spread":"0.762"},{"groupId":"OG003","value":"-0.62","spread":"0.707"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 52).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 52 and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":"0.652"},{"groupId":"OG001","value":"-0.53","spread":"0.643"},{"groupId":"OG002","value":"-0.29","spread":"0.744"},{"groupId":"OG003","value":"-0.53","spread":"0.790"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Final Visit).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at final visit and glycosylated hemoglobin collected at baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.42","spread":"0.838"},{"groupId":"OG001","value":"-0.58","spread":"0.791"},{"groupId":"OG002","value":"-0.44","spread":"0.720"},{"groupId":"OG003","value":"-0.58","spread":"0.781"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 8).","description":"The change between the value of fasting blood glucose collected at week 8 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.7","spread":"26.50"},{"groupId":"OG001","value":"-19.6","spread":"30.53"},{"groupId":"OG002","value":"-22.0","spread":"22.76"},{"groupId":"OG003","value":"-23.4","spread":"26.75"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 12).","description":"The change between the value of fasting blood glucose collected at week 12 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.0","spread":"32.19"},{"groupId":"OG001","value":"-18.1","spread":"29.05"},{"groupId":"OG002","value":"-22.9","spread":"24.04"},{"groupId":"OG003","value":"-24.2","spread":"27.30"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 16).","description":"The change between the value of fasting blood glucose collected at week 6 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.3","spread":"34.37"},{"groupId":"OG001","value":"-17.8","spread":"32.22"},{"groupId":"OG002","value":"-21.8","spread":"26.86"},{"groupId":"OG003","value":"-26.1","spread":"26.93"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 20).","description":"The change between the value of fasting blood glucose collected at week 20 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.4","spread":"31.75"},{"groupId":"OG001","value":"-22.3","spread":"30.93"},{"groupId":"OG002","value":"-23.4","spread":"27.88"},{"groupId":"OG003","value":"-26.1","spread":"26.19"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 24).","description":"The change between the value of fasting blood glucose collected at week 24 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.0","spread":"31.69"},{"groupId":"OG001","value":"-25.0","spread":"32.68"},{"groupId":"OG002","value":"-25.6","spread":"24.22"},{"groupId":"OG003","value":"-26.3","spread":"28.09"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 28).","description":"The change between the value of fasting blood glucose collected at week 28 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.9","spread":"36.87"},{"groupId":"OG001","value":"-25.9","spread":"33.67"},{"groupId":"OG002","value":"-25.8","spread":"26.16"},{"groupId":"OG003","value":"-28.2","spread":"29.49"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 32).","description":"The change between the value of fasting blood glucose collected at week 32 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.4","spread":"37.47"},{"groupId":"OG001","value":"-26.1","spread":"30.69"},{"groupId":"OG002","value":"-23.2","spread":"25.71"},{"groupId":"OG003","value":"-28.2","spread":"29.31"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 36).","description":"The change between the value of fasting blood glucose collected at week 36 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-25.5","spread":"34.16"},{"groupId":"OG001","value":"-26.7","spread":"33.12"},{"groupId":"OG002","value":"-23.4","spread":"24.00"},{"groupId":"OG003","value":"-26.0","spread":"31.26"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 40).","description":"The change between the value of fasting blood glucose collected at week 40 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21.3","spread":"33.44"},{"groupId":"OG001","value":"-22.7","spread":"30.19"},{"groupId":"OG002","value":"-19.8","spread":"24.81"},{"groupId":"OG003","value":"-23.2","spread":"31.13"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 44).","description":"The change between the value of fasting blood glucose collected at week 44 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.4","spread":"31.69"},{"groupId":"OG001","value":"-21.9","spread":"29.33"},{"groupId":"OG002","value":"-16.3","spread":"26.22"},{"groupId":"OG003","value":"-24.0","spread":"31.49"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 48).","description":"The change between the value of fasting blood glucose collected at week 48 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.6","spread":"28.29"},{"groupId":"OG001","value":"-16.6","spread":"30.68"},{"groupId":"OG002","value":"-14.3","spread":"24.22"},{"groupId":"OG003","value":"-23.3","spread":"29.73"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Week 52).","description":"The change between the value of fasting blood glucose collected at week 52 and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.3","spread":"31.74"},{"groupId":"OG001","value":"-11.9","spread":"30.11"},{"groupId":"OG002","value":"-14.0","spread":"26.92"},{"groupId":"OG003","value":"-16.1","spread":"29.60"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Blood Glucose (Final Visit).","description":"The change between the value of fasting blood glucose collected at final visit and baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.0","spread":"33.73"},{"groupId":"OG001","value":"-13.0","spread":"34.68"},{"groupId":"OG002","value":"-16.4","spread":"25.81"},{"groupId":"OG003","value":"-17.7","spread":"29.54"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by the Meal Tolerance Test (Week 12).","description":"The change between the value of blood glucose measured by the meal tolerance test collected at week 12 and blood glucose measured by the meal tolerance test collected at baseline. Meal tolerance test measures blood glucose through blood samples drawn before a meal and at 2 hours after the start of the meal.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80.2","spread":"43.24"},{"groupId":"OG001","value":"80.1","spread":"47.77"},{"groupId":"OG002","value":"61.6","spread":"38.72"},{"groupId":"OG003","value":"64.0","spread":"34.39"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by the Meal Tolerance Test (Week 24).","description":"The change between the value of blood glucose measured by the meal tolerance test collected at week 24 and blood glucose measured by the meal tolerance test collected at baseline. Meal tolerance test measures blood glucose through blood samples drawn before a meal and at 2 hours after the start of the meal.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"87.4","spread":"38.74"},{"groupId":"OG001","value":"77.9","spread":"42.68"},{"groupId":"OG002","value":"60.7","spread":"34.96"},{"groupId":"OG003","value":"62.4","spread":"32.23"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by the Meal Tolerance Test (Week 52).","description":"The change between the value of blood glucose measured by the meal tolerance test collected at week 52 and blood glucose measured by the meal tolerance test collected at baseline. Meal tolerance test measures blood glucose through blood samples drawn before a meal and at 2 hours after the start of the meal.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83.8","spread":"46.24"},{"groupId":"OG001","value":"83.2","spread":"43.61"},{"groupId":"OG002","value":"62.5","spread":"42.91"},{"groupId":"OG003","value":"62.7","spread":"32.81"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by the Meal Tolerance Test (Final Visit).","description":"The change between the value of blood glucose measured by the meal tolerance test collected at final visit and blood glucose measured by the meal tolerance test collected at baseline. Meal tolerance test measures blood glucose through blood samples drawn before a meal and at 2 hours after the start of the meal.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84.8","spread":"45.47"},{"groupId":"OG001","value":"84.9","spread":"44.35"},{"groupId":"OG002","value":"63.5","spread":"43.06"},{"groupId":"OG003","value":"63.7","spread":"32.32"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":150},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Back pain","Constipation","Diabetic retinopathy"]}}}